Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-07-021132
Filing Date
2007-03-23
Accepted
2007-03-23 17:27:24
Documents
1
Period of Report
2007-03-21

Document Format Files

Seq Description Document Type Size
1 GREENFIELD FORM 4 rrd152169.html 4  
1 GREENFIELD FORM 4 rrd152169.xml 4 3307
  Complete submission text file 0001181431-07-021132.txt   5287
Mailing Address 110 EAST 59TH STREET NEW YORK NY 10019
Business Address 110 EAST 59TH STREET NEW YORK NY 10019 250-519-0553
BRAINSTORM CELL THERAPEUTICS INC (Issuer) CIK: 0001137883 (see all company filings)

IRS No.: 912061050 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address P O B 12526 HERZLIYA PILEACH L3 46733
Business Address 972-52-277-7622
GREENFIELD MICHAEL D (Reporting) CIK: 0001311049 (see all company filings)

Type: 4 | Act: 34 | File No.: 333-61610 | Film No.: 07716123